-
Drug tissue concentration and STAT3 modulation as determinants of tofacitinib response in ulcerative colitis
Verstockt, B., Alsoud, D., van Oostrom, J., Verstockt, S., Smith, J., Stylli, J., Singh, S., van Gennep, S., Rahimian, P., Sabino, J., Ferrante, M., Kelman, A., Singh, S., D'Haens, G. & Vermeire, S., 1 May 2025, In: J. Crohn's Colitis. 19, 5, jjaf063.Research output: Contribution to journal › Article* › Academic › peer-review
-
Cost-effectiveness and cost-utility of optimized mercaptopurine treatment versus placebo in ulcerative colitis patients: The randomized controlled OPTIC trial
Löwenberg, M., van Barreveld, M., Volkers, A., van Gennep, S., Duijvestein, M., van Bodegraven, A. A., Hulshoff, M. S., Jansen, J. M., van Asseldonk, D., West, R., D’Haens, G., de Boer, N. & Dijkgraaf, M. G. W., Nov 2024, In: United European gastroenterology journal. 12, 9, p. 1256-1265 10 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Histological Outcomes and JAK-STAT Signalling in Ulcerative Colitis Patients Treated with Tofacitinib
Van Gennep, S., Fung, I. C. N., De Jong, D. C., Rishand, K. R., Clasquin, E., De Jong, J., De Vries, L. C. S., De Jonge, W. J., Gecse, K. B., Löwenberg, M., Woolcott, J. C., Mookhoek, A., D'Haensa, G. R. & D'Haens, G. R., 1 Aug 2024, In: Journal of Crohn's and Colitis. 18, 8, p. 1283-1291 9 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
